Abstract:Hepatitis B virus (HBV) infection is a global public health issue. We offer a comprehensive analysis of the dynamics of HBV, which can be successfully controlled with vaccine and treatment. Hepatitis B virus (HBV) causes a significantly more severe and protracted disease compared to hepatitis A. While it initially presents as an acute disease, in approximately 5 to 10% of cases, it can develop into a chronic disease that causes permanent damage to the liver. The hepatitis B virus can remain active outside the body for at least seven days. If the virus penetrates an individual's body without immunization, it may still result in infection. Upon exposure to HBV, the symptoms often last for a duration ranging from 10 days to 6 months. In this study, we developed a new model for Hepatitis B Virus (HBV) that includes asymptomatic carriers, vaccination, and treatment classes to gain a comprehensive knowledge of HBV dynamics. The basic reproduction number [Formula: see text] is calculated to identify future recurrence. The local and global stabilities of the proposed model are evaluated for values of [Formula: see text] that are both below and above 1. The Lyapunov function is employed to ensure the global stability of the HBV model. Further, the existence and uniqueness of the proposed model are demonstrated. To look at the solution of the proposed model graphically, we used a useful numerical strategy, such as the non-standard finite difference method, to obtain more thorough numerical findings for the parameters that have a significant impact on disease elimination. In addition, the study of treatment class in the population, we may assess the effectiveness of alternative medicines to treat infected populations can be determined. Numerical simulations and graphical representations are employed to illustrate the implications of our theoretical conclusions.

Ergodic Stationary Distribution of Age-Structured HBV Epidemic Model with Standard Incidence Rate

Mathematical analysis of a new nonlinear stochastic hepatitis B epidemic model with vaccination effect and a case study

A novel stochastic Hepatitis B virus epidemic model with second-order multiplicative α-stable noise and real data

A stochastic hepatitis B model with media coverage and Lévy noise

Understanding the dynamics of hepatitis B transmission: A stochastic model with vaccination and Ornstein-Uhlenbeck process

Dynamics of Hepatitis B Virus Transmission with a Lévy Process and Vaccination Effects

Dynamical behavior of a hepatitis B epidemic model and its NSFD scheme

Mathematical Model and Analysis of Transmission Dynamics of Hepatitis B Virus

Stationary distribution and extinction of a stochastic HIV/AIDS model with nonlinear incidence rate

Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes

Stochastic Optimal Control Analysis for HBV Epidemic Model with Vaccination

Perturbation of a globally stable equilibrium: application on an age-structured model

Dynamic behaviors of a stochastic virus infection model with Beddington–DeAngelis incidence function, eclipse-stage and Ornstein–Uhlenbeck process

Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment

Analysis of a model for hepatitis C virus transmission that includes the effects of vaccination with waning immunity

Dynamic analysis of a stochastic SVEIR epidemic model with saturated incidence and partial vaccination

Stochastic modeling and computational simulations of HBV infection dynamics

Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach

Dynamical analysis of a generalized hepatitis B epidemic model and its dynamically consistent discrete model

Dynamic analysis of an HIV model with CTL immune response and logarithmic Ornstein–Uhlenbeck process

Bifurcation and theoretical analysis of a fractional-order Hepatitis B epidemic model incorporating different chronic stages of infection